ArticleOpen forum infectious diseases2020

Evaluation of Renal Safety Between Imipenem/Relebactam and Colistin Plus Imipenem in Patients With Imipenem-Nonsusceptible Bacterial Infections in the Randomized, Phase 3 RESTORE-IMI 1 Study.

Michelle L Brown et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.